These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 26985693)
1. Naked Polyamidoamine Polymers Intrinsically Inhibit Angiotensin II-Mediated EGFR and ErbB2 Transactivation in a Dendrimer Generation- and Surface Chemistry-Dependent Manner. Akhtar S; El-Hashim AZ; Chandrasekhar B; Attur S; Benter IF Mol Pharm; 2016 May; 13(5):1575-86. PubMed ID: 26985693 [TBL] [Abstract][Full Text] [Related]
2. Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo. Akhtar S; Al-Zaid B; El-Hashim AZ; Chandrasekhar B; Attur S; Yousif MH; Benter IF PLoS One; 2015; 10(7):e0132215. PubMed ID: 26167903 [TBL] [Abstract][Full Text] [Related]
3. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor. Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway. Akhtar S; Yousif MH; Dhaunsi GS; Chandrasekhar B; Al-Farsi O; Benter IF Br J Pharmacol; 2012 Mar; 165(5):1390-400. PubMed ID: 21806601 [TBL] [Abstract][Full Text] [Related]
5. Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor. Akhtar S; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Benter IF PLoS One; 2015; 10(11):e0141657. PubMed ID: 26536590 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor. Bokemeyer D; Schmitz U; Kramer HJ Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078 [TBL] [Abstract][Full Text] [Related]
7. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024 [TBL] [Abstract][Full Text] [Related]
8. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. Kim J; Ahn S; Rajagopal K; Lefkowitz RJ J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952 [TBL] [Abstract][Full Text] [Related]
9. Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR. Sandoval YH; Li Y; Anand-Srivastava MB Cell Signal; 2011 Nov; 23(11):1716-26. PubMed ID: 21712088 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A(2)-mediated release of arachidonic acid. Freeman EJ; Sheakley ML; Clements RJ Arch Biochem Biophys; 2010 Jun; 498(1):50-6. PubMed ID: 20388488 [TBL] [Abstract][Full Text] [Related]
11. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells. Bouallegue A; Vardatsikos G; Srivastava AK Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537 [TBL] [Abstract][Full Text] [Related]
12. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716 [TBL] [Abstract][Full Text] [Related]
13. Chronic administration of nano-sized PAMAM dendrimers in vivo inhibits EGFR-ERK1/2-ROCK signaling pathway and attenuates diabetes-induced vascular remodeling and dysfunction. Akhtar S; Chandrasekhar B; Yousif MH; Renno W; Benter IF; El-Hashim AZ Nanomedicine; 2019 Jun; 18():78-89. PubMed ID: 30844576 [TBL] [Abstract][Full Text] [Related]
14. Impact of PAMAM delivery systems on signal transduction pathways in vivo: Modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney. Akhtar S; Al-Zaid B; El-Hashim AZ; Chandrasekhar B; Attur S; Benter IF Int J Pharm; 2016 Dec; 514(2):353-363. PubMed ID: 27032566 [TBL] [Abstract][Full Text] [Related]
15. On the nanotoxicity of PAMAM dendrimers: Superfect® stimulates the EGFR-ERK1/2 signal transduction pathway via an oxidative stress-dependent mechanism in HEK 293 cells. Akhtar S; Chandrasekhar B; Attur S; Yousif MH; Benter IF Int J Pharm; 2013 May; 448(1):239-46. PubMed ID: 23538097 [TBL] [Abstract][Full Text] [Related]
16. Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells. Gomez Sandoval YH; Lévesque LO; Anand-Srivastava MB Can J Physiol Pharmacol; 2009 Dec; 87(12):1037-45. PubMed ID: 20029540 [TBL] [Abstract][Full Text] [Related]
17. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation. Bourmoum M; Charles R; Claing A PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355 [TBL] [Abstract][Full Text] [Related]
18. Thrombin induces nestin expression via the transactivation of EGFR signalings in rat vascular smooth muscle cells. Huang YL; Shi GY; Lee H; Jiang MJ; Huang BM; Wu HL; Yang HY Cell Signal; 2009 Jun; 21(6):954-68. PubMed ID: 19245830 [TBL] [Abstract][Full Text] [Related]
19. Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Andresen BT; Linnoila JJ; Jackson EK; Romero GG Hypertension; 2003 Mar; 41(3 Pt 2):781-6. PubMed ID: 12623996 [TBL] [Abstract][Full Text] [Related]